Procter & Gamble Hygiene and Health Care (500459) Investor Day 2026 summary

Financial performance and outlook

• Sales for FY ending March 2026 were INR 4,300 crore, flat year-over-year, while profit after tax rose 19% to INR 850 crore, reflecting strong productivity and margin expansion.

• Over the past decade, sales and profits have approximately doubled, with a compounded annual profit growth of 8% and net profit margin up 200 basis points; net sales achieved a 6% CAGR and PAT an 8% CAGR, with a threefold increase in ROE.

• Shareholder value creation is evidenced by 30 years of consistent dividends and a share price that has more than doubled in the last decade.

• The company aims for long-term growth, focusing on growing ahead of the market, improving margins, and sustained value creation despite macroeconomic headwinds.

• FMCG industry growth remains positive, with feminine hygiene growing at 7-10% and healthcare at 2-3%, though both face volatility and evolving consumer trends.

Strategic priorities and business developments

• The integrated growth strategy centers on delivering superiority in product, packaging, brand communication, retail execution, and value, with a focus on portfolio strength and constructive disruption.

• Productivity programs delivered INR 86 crore in savings last year, fueling reinvestment in innovation and margin expansion.

• Investments in innovation include upgrades to core products like Whisper Period Pads and Nights, Vicks Cough Syrup, and ZzzQuil Natura Sleep Gummies, as well as new period protection products and nutraceuticals.

• Data-driven execution and AI-led tools have optimized go-to-market strategies, improved availability, and enabled double-digit portfolio optimization; investments in data platforms and AI aim to drive operational efficiency and consumer insights.

• Lean innovation and supply chain digitization are central to ongoing constructive disruption.

Brand and product development

• Whisper Period Panties, a new segment, has seen rapid adoption, selling over 10 crore units in the last year and tripling business.

• Enhanced product offerings in feminine care (Whisper) and health care (Vicks) drive consumer preference.

• Superior product, packaging, communication, and retail execution drive consumer preference.

• Retail execution leverages fast delivery and digital platforms to reach consumers efficiently.